Publishers Seek to Join Lawsuit Against Google Over Alleged AI Copyright Infringement 
U.S. Transportation Board Sends Union Pacific–Norfolk Southern Merger Back for Revision 
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive 
Anthropic Appoints Former Microsoft Executive Irina Ghose to Lead India Expansion 
BYD Shares Rise in Hong Kong on Reports of Battery Supply Talks With Ford 
Toyota Industries Buyout Faces Resistance as Elliott Rejects Higher Offer 
White House Pressures PJM to Act as Data Center Energy Demand Threatens Grid Reliability 
TSMC Shares Hit Record High as AI Chip Demand Fuels Strong Q4 Earnings 
U.S. Moves to Expand Chevron License and Control Venezuelan Oil Sales 
Chevron Set to Expand Venezuela Operations as U.S. Signals Shift on Oil Sanctions 
One Percent Rule Checklist For Safer Forex Trading Risk 
Boeing Reaches Tentative Labor Deal With SPEEA Workers After Spirit AeroSystems Acquisition 
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal 
China Considers New Rules to Limit Purchases of Foreign AI Chips Amid Growing Demand 
California Attorney General Orders xAI to Halt Illegal Grok Deepfake Imagery 
Federal Judge Clears Way for Jury Trial in Elon Musk’s Fraud Lawsuit Against OpenAI and Microsoft 
TikTok Expands AI Age-Detection Technology Across Europe Amid Rising Regulatory Pressure 
AUDUBON, Pa., April 17, 2017 -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, will announce its financial results for the first quarter ended March 31, 2017 after the market close on Wednesday, May 3, 2017. A copy of the release will be available on the Globus Medical website at www.globusmedical.com/investors.
Following the announcement, Globus Medical will hold a teleconference to discuss its performance with the investment community at 5:30 p.m. Eastern Time. Globus invites all interested parties to join the call by dialing:
1-855-533-7141 United States Participants
1-720-545-0060 International Participants
There is no passcode for the teleconference.
For interested parties who do not wish to ask questions, the teleconference will be webcast live and may be accessed through a link on the Globus Medical website at www.globusmedical.com/investors.
The call will be archived until Monday, May 9, 2017. The audio archive can be accessed by calling 1-855-859-2056 in the U.S. or 1-404-537-3406 from outside the U.S. The passcode for the audio replay is 889-7466.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal implant company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at www.globusmedical.com.
Dan Scavilla Senior Vice President and Chief Financial Officer Phone: (610) 930-1800 Email: [email protected] www.globusmedical.com
